Botanical species · safety record

Litsea glutinosa

The EFSA Compendium of Botanicals holds 11 constituent measurements for Litsea glutinosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Litsea glutinosa (Lour.) C.B.Rob.

11Constituent measurements

0Safety records

7Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Aporphine alkaloids	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Furan derivatives	Wood	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Methyleugenol	Leaves	Essential oil	1.2 Percent	GC-FID	Resolve DOI
Myrcene	Leaves	Essential oil	1 Percent	GC-FID	Resolve DOI
Alkaloids	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Alkaloids	Bark	Solvent extraction	0.32 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Alkaloids	Leaves	Solvent extraction	0.24 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Epoxides	Leaves	Essential oil	2.79 Percent	GC-MS	No resolvable identifier
Lignans	Stem / stalk	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Myrcene	Leaves	Essential oil	5 Percent	GC-MS	No resolvable identifier
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Khatun Amina., Haque Tania., Akter Mahfuja., Akter Subarna., Jhumur Afrin., Rahman Mahmudur., Rahman Md Mahfizur. Cytotoxicity potentials of eleven Bangladeshi medicinal plants. Thescientificworldjournal, 2014.
Yang, JH., Li, L., Wang, YS., Zhao, JF., Zhang, HB., Luo, SD. Two new aporphine alkaloids from Litsea glutinosa. Helvetica chimica acta, 2005, vol. 88, no. 9, p. 2523-2526. DOI
Chowdhury, Jasim Uddin., Bhuiyan, Md. Nazrul Islam., Nandi, Nemai Chandra. Aromatic plants of Bangladesh: Essential oils of leaves and fruits of Litsea glutinosa (Lour.) C.B. Robinson . Bangladesh journal of botany, 2008, vol. 37, no. 1, p. 81-83.
Son, Le C., Dai, Do N., Thang, Tran D., Huyen, Duong D., Ogunwande, Isiaka A. Analysis of the Essential Oils from Five Vietnamese Litsea Species (Lauraceae) . Journal of essential oil bearing plants, 2014, vol. 17, no. 5, p. 960-971. DOI
Pan, Jian-Yu., Zhang, Si., Wu, Jun., Li, Qing-Xin., Xiao, Zhi-Hui. Litseaglutinan A and Lignans from Litsea glutinosa. Helvetica chimica acta, 2010, vol. 93, no. 5, p. 951-957.
Agrawal, Nisha., Pareek, Deepika., Dobhal, Sonal., Sharma, Mahesh C., Joshi, Yogesh C., Dobhal, Mahabeer P. Butanolides from Methanolic Extract of Litsea glutinosa. Chemistry & biodiversity, 2013, vol. 10, no. 3, p. 394-400. DOI
Hart, N. K., Johns, S. R., Lamberton, John A., Loder, John W., Moorhouse, Anne., Sioumis, A. A., Smith, T. K. Alkaloids of several Litsea species from New Guinea. Australian journal of chemistry, 1969, p. 2259-2262.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature